🇺🇸 FDA
Patent

US 8821884

Compositions and methods using MD-2 mutants and chimeric proteins

granted A61KA61K38/00A61P

Quick answer

US patent 8821884 (Compositions and methods using MD-2 mutants and chimeric proteins) held by The Regents of the University of California expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00, A61P, A61P43/00